Danaher Corporation $DHR Shares Bought by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. boosted its stake in shares of Danaher Corporation (NYSE:DHR) by 290.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 56,188 shares of the conglomerate’s stock after purchasing an additional 41,780 shares during the period. First Citizens Bank & Trust Co.’s holdings in Danaher were worth $12,448,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Focus Financial Network Inc. boosted its stake in shares of Danaher by 163.1% in the third quarter. Focus Financial Network Inc. now owns 26,939 shares of the conglomerate’s stock worth $5,968,000 after buying an additional 16,699 shares during the last quarter. Roberts Wealth Advisors LLC purchased a new position in Danaher during the third quarter valued at approximately $1,936,000. Enclave Advisors LLC lifted its holdings in Danaher by 104.9% in the third quarter. Enclave Advisors LLC now owns 5,102 shares of the conglomerate’s stock valued at $1,130,000 after acquiring an additional 2,612 shares during the period. Salem Investment Counselors Inc. lifted its holdings in Danaher by 1,462.8% in the third quarter. Salem Investment Counselors Inc. now owns 8,939 shares of the conglomerate’s stock valued at $1,980,000 after acquiring an additional 8,367 shares during the period. Finally, Keystone Financial Group Inc. acquired a new position in Danaher in the third quarter valued at approximately $640,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE DHR opened at $223.30 on Wednesday. The firm has a market cap of $156.98 billion, a PE ratio of 39.66, a PEG ratio of 2.78 and a beta of 0.76. The firm has a fifty day moving average of $212.41 and a 200 day moving average of $195.13. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.77 earnings per share. As a group, research analysts predict that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s payout ratio is presently 28.42%.

Analyst Ratings Changes

Several equities research analysts have commented on the company. Evercore restated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. TD Cowen lifted their target price on shares of Danaher from $236.00 to $255.00 and gave the company a “buy” rating in a report on Tuesday. Guggenheim lifted their target price on shares of Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a report on Thursday, October 1st. Weiss Ratings upgraded shares of Danaher from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, September 16th. Finally, The Goldman Sachs Group boosted their target price on shares of Danaher from $210.00 to $250.00 and gave the company a “buy” rating in a research note on Monday, September 21st. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $235.41.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.